Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel patented route for high-purity nucleoside intermediates. Enhances solubility and yield for nucleic acid drug manufacturing supply chains.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Novel synthesis route for hypoglycemic drug molecule TAPA offering high yield and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN112538068A reveals a novel acid-catalyzed route for electron-rich heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108017594B reveals a safer one-pot synthesis replacing carbon disulfide, offering cost reduction and environmental benefits for pharmaceutical intermediates manufacturing.
Novel organophosphine-catalyzed asymmetric [4+2] cycloaddition for high-purity chiral 3,4-dihydroquinazolin-2-ones. Scalable route with excellent enantioselectivity up to 92% ee.
Novel catalytic oxidation process for 4-HMFA and 2 4-FDCA offering enhanced purity and scalable production capabilities for global supply chains.
Novel patent CN105873938A details a high-yield regadenoson process avoiding genotoxic impurities ensuring supply chain stability and cost reduction in API manufacturing.
Patent CN105483749A details a green pairwise electrosynthesis method for pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN103044315A reveals solvent-free 1,4-dihydropyridine synthesis. Acidic ionic liquid catalyst ensures high yield and supply chain reliability for pharmaceutical intermediates.
Patent CN104529803B reveals a novel amide synthesis route using triethylenediamine. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity.
Novel slurry purification method controls 2-ethylpentanoic acid impurity ensuring European Pharmacopoeia compliance and supply chain stability for pharmaceutical intermediates.
Patent CN102712593B reveals improved synthesis using hydrophilic ethers. Achieves high purity and reduced reaction time for scalable pharmaceutical intermediates manufacturing.
Patent CN101535290A reveals a protective-group-free hydrogenation method for 2-alkyl-3-aminothiophene derivatives, offering significant cost reduction and scalable manufacturing for agrochemical intermediates.
Novel resolution process for chiral piperidine intermediates. Reduces steps and cost for pharmaceutical manufacturing. Reliable supply chain partner.
Patent CN1452621A details a novel cyclohexanone-based route for substituted imidazopyridines, offering superior yields and scalability for gastric acid inhibitor intermediates.
Novel catalyst-free method improves yield and safety for benzimidazole derivatives, offering cost-effective supply chain solutions.
Patent CN106589037A reveals a novel two-step progesterone synthesis. Achieve high purity and cost reduction in hormone manufacturing with scalable industrial processes.
Patent CN1345310A reveals a novel base-mediated carboxylation route for 3,4-dehydroprolines, offering safer manufacturing and cost reduction in API intermediate production.